T. Manigold and G. Gosselin, Aggressive medical therapy for stable coronary disease: with or without percutaneous coronary intervention (COURAGE trial)

N. Jacquiot and Y. Cottin, [Long-term management of the stable coronary patient. The optimization of the medical treatment: a real objective], Ann Cardiol Angeiol, vol.57, pp.9-15, 2008.

J. Tardif, Clinical Results of If Current Inhibition by Ivabradine, Drugs, vol.27, issue.4, pp.35-41, 2007.
DOI : 10.2165/00003495-200767002-00005

A. Chagas, P. Dourado, and T. Galvão, Modulation of Cardiac Metabolism During Myocardial Ischemia, Current Pharmaceutical Design, vol.14, issue.25, pp.2563-71, 2008.
DOI : 10.2174/138161208786071236

D. Napoli, P. , D. Giovanni, P. Gaeta, M. Taccardi et al., Trimetazidine and Reduction in Mortality and Hospitalization in Patients With Ischemic Dilated Cardiomyopathy: A Post Hoc Analysis of the Villa Pini D??Abruzzo Trimetazidine Trial, Journal of Cardiovascular Pharmacology, vol.50, issue.5, pp.585-594, 2007.
DOI : 10.1097/FJC.0b013e31814fa9cb

W. Banasiak, A. Wilkins, R. Pociupany, and P. Ponikowski, Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in

. Poland, Results of the multicentre RECENT study, Kardiol Pol, vol.66, pp.642-651, 2008.

A. Aubert, C. Bernard, P. Clauser, C. Harpey, and H. Vaudry, [A cellular antiischemic agent, trimetazidine prevents the deleterious effects of oxygen freeradicals on the internal ear], Ann Otolaryngol Chir Cervicofac, vol.107, pp.28-35, 1990.

A. Coyas, The efficacy of trimetazidine in cochleovestibular disorders of ischemic origin. A crossover control versus placebo trial], Ann Otolaryngol Chir Cervicofac, vol.107, pp.82-89, 1990.

M. Banach, J. Rysz, A. Goch, D. Mikhailidis, and G. Rosano, The Role of Trimetazidine After Acute Myocardial Infarction, Current Vascular Pharmacology, vol.6, issue.4, pp.282-91, 2008.
DOI : 10.2174/157016108785909788

F. Vaillant, P. Tsibiribi, G. Bricca, B. Bui-xuan, A. Bescond-jacquet et al., Trimetazidine Protective Effect Against Ischemia-Induced Susceptibility to Ventricular Fibrillation in Pigs, Cardiovascular Drugs and Therapy, vol.79, issue.1, pp.29-36, 2008.
DOI : 10.1007/s10557-007-6076-5

D. Panagiotakos, C. Pitsavos, F. Arvaniti, and C. Stefanadis, Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore, Preventive Medicine, vol.44, issue.4, pp.335-375, 2007.
DOI : 10.1016/j.ypmed.2006.12.009

D. Arveiler, A. Wagner, P. Ducimetière, M. Montaye, J. Ruidavets et al., Trends in coronary heart disease in France during the second half of the 1990s, European Journal of Cardiovascular Prevention & Rehabilitation, vol.104, issue.8, pp.209-224, 2005.
DOI : 10.1097/00149831-200506000-00004

A. Wagner, D. Arveiler, M. Montaye, J. Ruidavets, A. Bingham et al., Les données récentes des registres français des cardiopathies ischémiques, p.19, 2006.

A. Berdeaux, La cardioprotection pharmacologique contre l???infarctus du myocarde : r??alit??s et actualit??s, Annales Pharmaceutiques Fran??aises, vol.65, issue.5, pp.315-339, 2007.
DOI : 10.1016/S0003-4509(07)92594-8

G. Ren, O. Dewald, and N. Frangogiannis, Inflammatory Mechanisms in Myocardial Infarction, Current Drug Target -Inflammation & Allergy, vol.2, issue.3, pp.242-56, 2003.
DOI : 10.2174/1568010033484098

V. Kutala, M. Khan, R. Mandal, L. Ganesan, S. Tridandapani et al., Attenuation of Myocardial Ischemia-Reperfusion Injury by Trimetazidine Derivatives Functionalized with Antioxidant Properties, Journal of Pharmacology and Experimental Therapeutics, vol.317, issue.3, pp.921-929, 2006.
DOI : 10.1124/jpet.105.100834

J. De-leiris and F. Boucher, Rationale for trimetazidine administration in myocardial ischaemia--reperf usion syndrome, European Heart Journal, vol.14, issue.suppl G, pp.34-40, 1993.
DOI : 10.1093/eurheartj/14.suppl_G.34

H. Brömme and J. Holtz, Apoptosis in the heart: when and why?, Mol Cell Biochem, vol.163, pp.261-75, 1996.
DOI : 10.1007/978-1-4613-1289-5_33

G. Kroemer, B. Dallaporta, and M. Resche-rigon, THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS, Annual Review of Physiology, vol.60, issue.1, pp.619-661, 1998.
DOI : 10.1146/annurev.physiol.60.1.619

Y. Woo, Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction, Heart Lung Circ, vol.15, pp.119-142, 2006.

M. Janier, J. Vanoverschelde, and S. Bergmann, Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanisms, Am J Physiol, vol.264, pp.163-70, 1993.

K. Carvajal and R. Moreno-sánchez, Heart Metabolic Disturbances in Cardiovascular Diseases, Archives of Medical Research, vol.34, issue.2, pp.89-99, 2003.
DOI : 10.1016/S0188-4409(03)00004-3

G. Fragasso, A. Salerno, R. Spoladore, G. Bassanelli, F. Arioli et al., Metabolic Therapy of Heart Failure, Current Pharmaceutical Design, vol.14, issue.25, pp.2582-91, 2008.
DOI : 10.2174/138161208786071245

M. Lindbom, T. Ramunddal, G. Camejo, F. Waagstein, and E. Omerovic, In Vivo Effects of Myocardial Creatine Depletion on Left Ventricular Function Morphology and Lipid Metabolism: Study in a Mouse Model, Journal of Cardiac Failure, vol.14, issue.2, pp.161-167, 2008.
DOI : 10.1016/j.cardfail.2007.10.020

D. Chlubek, Hypoxanthine as a graft ischemia marker stimulates catalase activity in the renal vein during reperfusion in humans, Transplant Proc, vol.38, pp.35-43, 2006.

J. P. Camilleri, D. Joseph, D. Amat, and J. N. Fabiani, Impaired sarcolemnal permeability in reperfused ischemic myocardium

A. Shug and R. Subramanian, Modulation of adenine nucleotide translocase activity during myocardial ischemia, Z Kardiol, vol.76, pp.26-33, 1987.

R. Jennings, K. Reimer, M. Hill, and S. Mayer, Total ischemia in dog hearts, in vitro. 1. Comparison of high energy phosphate production, utilization, and depletion, and of adenine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in vivo, Circulation Research, vol.49, issue.4, pp.892-900, 1981.
DOI : 10.1161/01.RES.49.4.892

D. Laky, L. Parascan, and V. Cândea, Myocardial stunning. Morphological studies in acute experimental ischemia and intraoperatory myocardial biopsies

H. Saini, V. Elimban, A. Ozcelikay, and N. Dhalla, -isobutyl amiloride (MIA) on the heart: lack of beneficial effects in ischemia???reperfusion injuryThis paper is one of a selection of papers published in this Special Issue, entitled Young Investigators' Forum., Canadian Journal of Physiology and Pharmacology, vol.85, issue.1, pp.67-78, 2007.
DOI : 10.1139/Y06-099

URL : https://hal.archives-ouvertes.fr/dumas-00636803

R. Jennings and C. Ganote, Mitochondrial structure and function in acute myocardial ischemic injury, Cir Res, vol.38, issue.1, pp.80-89, 1976.

S. Lindal, O. Smiseth, O. Mjøs, R. Myklebust, and L. Jørgensen, REVERSIBLE AND IRREVERSIBLE CHANGES IN THE DOG HEART DURING ACUTE LEFT VENTRICULAR FAILURE DUE TO EXPERIMENTAL MULTIFOCAL ISCHAEMIA, Acta Pathologica Microbiologica Scandinavica Series A :Pathology, vol.2, issue.Suppl. I, pp.177-86, 1986.
DOI : 10.1111/j.1699-0463.1986.tb02983.x

G. Zeng, Pathological study of unexpected sudden death clustered in family or village in Yunnan province: report of 29 cases of autopsy, Zhonghua Yi Xue Za Zhi, vol.87, pp.2209-2223, 2007.

K. Hwang, S. Lim, H. Kwon, Y. Bae, S. Kang et al., Phospholipase C-??1 rescues intracellular Ca2+ overload in ischemic heart and hypoxic neonatal cardiomyocytes, The Journal of Steroid Biochemistry and Molecular Biology, vol.91, issue.3, pp.131-139, 2004.
DOI : 10.1016/j.jsbmb.2004.02.009

N. Dhalla, H. Saini, P. Tappia, R. Sethi, S. Mengi et al., Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease, Journal of Cardiovascular Medicine, vol.8, issue.4, pp.238-50, 2007.
DOI : 10.2459/01.JCM.0000263489.13479.68

L. Fliegel, Molecular biology of the myocardial Na+/H+ exchanger, Journal of Molecular and Cellular Cardiology, vol.44, issue.2, pp.228-265, 2008.
DOI : 10.1016/j.yjmcc.2007.11.016

G. Olivetti, R. Abbi, F. Quaini, J. Kajstura, W. Cheng et al., Apoptosis in the Failing Human Heart, New England Journal of Medicine, vol.336, issue.16, pp.1131-1172, 1997.
DOI : 10.1056/NEJM199704173361603

J. Tillement, (3)H]-trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance, Br J Pharmacol, vol.130, pp.655-63, 2000.

V. Sakac and M. Sakac, [Free oxygen radicals and kidney diseases-part I], Med Pregl, vol.53, pp.463-74, 2000.

G. Bulkley, Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function, The Lancet, vol.344, issue.8927, pp.934-936, 1994.
DOI : 10.1016/S0140-6736(94)92276-4

S. Bertuglia and A. Giusti, Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion, American Journal of Physiology - Heart and Circulatory Physiology, vol.285, issue.3, pp.1064-71, 2003.
DOI : 10.1152/ajpheart.00124.2003

S. Bertuglia and A. Giusti, Microvascular Oxygenation and Oxidative Stress During Postischemic Reperfusion, Adv Exp Med Biol, vol.566, pp.23-32, 2005.
DOI : 10.1007/0-387-26206-7_4

T. Nishino, K. Okamoto, B. Eger, E. Pai, and T. Nishino, Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase, FEBS Journal, vol.281, issue.13, pp.3278-89, 2008.
DOI : 10.1111/j.1742-4658.2008.06489.x

C. Berry and J. Hare, Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications, The Journal of Physiology, vol.3, issue.3, pp.589-606, 2004.
DOI : 10.1113/jphysiol.2003.055913

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1664875

S. Goldstein, D. Meyerstein, and G. Czapski, The Fenton reagents, Free Radical Biology and Medicine, vol.15, issue.4, pp.435-480, 1993.
DOI : 10.1016/0891-5849(93)90043-T

D. Virgilio and F. , New Pathways for Reactive Oxygen Species Generation in Inflammation and Potential Novel Pharmacological Targets, Current Pharmaceutical Design, vol.10, issue.14, pp.1647-52, 2004.
DOI : 10.2174/1381612043384727

K. Rahman, Studies on free radicals, antioxidants, and co-factors, Clin Interv Aging, vol.2, pp.219-255, 2007.

L. Macmillan-crow and D. Cruthirds, Manganese superoxide dismutase in disease, Free Radical Research, vol.96, issue.8, pp.325-361, 2001.
DOI : 10.1002/(SICI)1097-0045(19980515)35:3<221::AID-PROS8>3.0.CO;2-J

F. Johnson and C. Giulivi, Superoxide dismutases and their impact upon human health, Molecular Aspects of Medicine, vol.26, issue.4-5, pp.340-52, 2005.
DOI : 10.1016/j.mam.2005.07.006

H. Hassan and I. Fridovich, Chemistry and biochemistry of superoxide dismutases, Eur J Rheumatol Inflamm, vol.4, pp.160-72, 1981.

M. Ba?liak, O. Abrat, H. Semchyshyn, and V. Lushchak, [Survival and antioxidant defence of the yeast Saccharomyces cerevisiae during starvation and oxidative stress], Ukr Biokhim Zh, vol.77, pp.93-101, 2005.

S. Izawa, Y. Inoue, and A. Kimura, Importance of catalase in the adaptive response to hydrogen peroxide: analysis of acatalasaemic Saccharomyces cerevisiae

H. Imai, Biological Significance of Lipid Hydroperoxide and Its Reducing Enzyme, Phospholipid Hydroperoxide Glutathione Peroxidase in Mammalian Cells, ChemInform, vol.124, issue.17
DOI : 10.1002/chin.200517283

P. Stocker, J. Lesgards, N. Vidal, F. Chalier, and M. Prost, ESR study of a biological assay on whole blood: antioxidant efficiency of various vitamins, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1621, issue.1
DOI : 10.1016/S0304-4165(03)00008-4

J. Gutteridge, Inhibition of the Fenton reaction by the protein caeruloplasmin and other copper complexes. Assessment of ferroxidase and radical scavenging activities, Chemico-Biological Interactions, vol.56, issue.1, pp.113-133, 1985.
DOI : 10.1016/0009-2797(85)90043-2

J. Kehrer, The Haber???Weiss reaction and mechanisms of toxicity, Toxicology, vol.149, issue.1
DOI : 10.1016/S0300-483X(00)00231-6

J. Spear, Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation, Circulation, vol.59, issue.2, p.247, 1979.
DOI : 10.1161/01.CIR.59.2.247

L. Opie, The Heart, Grune and strattoned, 1984.

L. Rochette, J. Didier, D. Moreau, J. Bralet, and L. Opie, Role of beta-adrenoreceptor antagonism in the prevention of reperfusion ventricular arrhythmias: Effects of acebutolol, atenolol, and d-propranolol on isolated working rat hearts subject to myocardial ischemia and reperfusion, American Heart Journal, vol.107, issue.6, pp.1132-1141, 1984.
DOI : 10.1016/0002-8703(84)90268-0

R. Shaw and R. Y. , Electrophysiologic effects of acute myocardial ischemia: a theoretical study of altered cell excitability and action potential duration, Cardiovascular Research, vol.35, issue.2
DOI : 10.1016/S0008-6363(97)00093-X

L. Schamroth, The electrocardiology of coronary artery disease (sec

A. Berger, J. Meier, J. Stauffer, P. Eckert, J. Schlaepfer et al., ECG interpretation during the acute phase of coronary syndromes: in need of improvement?, Swiss Med Wkly, vol.134, pp.695-704, 2004.

A. Mincholé, F. Jager, and P. Laguna, Discrimination between Demand and Supply Ischemia Episodes in Holter Recordings, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pp.2579-82, 2007.
DOI : 10.1109/IEMBS.2007.4352856

G. Morace and L. Alcidi, Monitoring of ischemic changes of the QRS complex with a new system of computerized electrocardiography], Ital Heart J Suppl, vol.1, pp.1464-71, 2000.

M. Matveev, V. Krasteva, S. Naydenov, and T. Donova, Possibilities of signalaveraged orthogonal and vector electrocardiography for locating and size evaluation of acute myocardial infarction with ST-elevation, Anadolu Kardiyol Derg, vol.7, pp.193-200, 2007.

P. Oliva and J. Breckinridge, Arteriographic evidence of coronary arterial spasm in acute myocardial infarction, Circulation, vol.56, issue.3, p.366, 1977.
DOI : 10.1161/01.CIR.56.3.366

E. W. Reynolds, R. Van-der-ark, and F. D. Johnston, Effect of Acute Myocardial Infarction on Electrical Recovery and Transmural Temperature Gradient in Left Ventricular Wall of Dogs, Circulation Research, vol.8, issue.4, p.730, 1960.
DOI : 10.1161/01.RES.8.4.730

R. Haiat and P. Chiche, Transient Abnormal Q Waves in the Course of Ischemic Heart Disease, Chest, vol.65, issue.2, p.140, 1974.
DOI : 10.1378/chest.65.2.140

R. Cook, J. Edwards, and R. Pruitt, Electrocardiographic changes in acute subendocardial infarction. I Large subendocardial and Large non transmural infarcts, Circulation, vol.18, p.6035, 1958.

B. Crozatier, Effets de l'ischémie et de la reperfusion sur la fonction contractile du myocarde, Inf Cardiol, vol.10, p.113, 1985.

F. Piscione, P. Hugenholtz, and P. Serruys, Impaired left ventricular filling dynamics during percutaneous transluminal angioplasty for coronary artery disease, The American Journal of Cardiology, vol.59, issue.1, p.29, 1987.
DOI : 10.1016/S0002-9149(87)80064-4

W. Gaash, Myocardial contracture during prolonged ischemic arrest and reperfusion, Am J Physiol, vol.235, p.619, 1978.

G. Geary, G. Smith, M. Namara, and J. , Quantitative effect of early coronary artery reperfusion in baboons. Extent of salvage of the perfusion bed of an occluded artery, Circulation, vol.66, issue.2, p.391, 1982.
DOI : 10.1161/01.CIR.66.2.391

E. Braunwald and R. Kloner, The stunned myocardium: prolonged, postischemic ventricular dysfunction, Circulation, vol.66, issue.6, p.1146, 1982.
DOI : 10.1161/01.CIR.66.6.1146

H. Friedman, Determinants of the total cosine of the spatial angle between the QRS complex and the T wave (TCRT): implications for distinguishing primary from secondary T-wave abnormalities, Journal of Electrocardiology, vol.40, issue.1, pp.12-19, 2007.
DOI : 10.1016/j.jelectrocard.2006.05.008

E. Braunwald, Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?, Circulation, vol.79, issue.2, pp.441-444, 1989.
DOI : 10.1161/01.CIR.79.2.441

R. Kloner, C. Ganote, and R. Jennings, The ???No-Reflow??? Phenomenon after Temporary Coronary Occlusion in the Dog, Journal of Clinical Investigation, vol.54, issue.6, pp.1496-1508, 1974.
DOI : 10.1172/JCI107898

J. De-leiris and F. Boucher, Ischemic myocardial cell necrosis: calcium overload or oxygen free-radicals?, Rev Port Cardiol, vol.9, pp.153-161, 1990.

A. Barsotti, D. Napoli, and P. , Trimetazidine and cardioprotection during ischemiareperfusion, Ital Heart J, vol.5, pp.29-36, 2004.

J. Kajstura, Y. Liu, A. Baldini, B. Li, G. Olivetti et al., Coronary artery constriction in rats: necrotic and apoptotic myocyte death, The American Journal of Cardiology, vol.82, issue.5, pp.30-41, 1998.
DOI : 10.1016/S0002-9149(98)00535-9

D. Robert and M. Ovize, Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury, J Mol Cell Cardiol, vol.39, pp.893-902, 2005.

G. Calori, G. Lopaschuk, and A. Margonato, Short-and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy, American heart journal, vol.146, p.18, 2003.

G. Fragasso, C. Montano, G. Perseghin, A. Palloshi, G. Calori et al., The antiischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition, American heart journal, vol.51, p.1238, 2006.

P. Blardi, A. De-lalla, L. Volpi, A. Auteri, D. Perri et al., Increase of adenosine plasma levels after oral trimetazidine: a pharmacological preconditioning?, Pharmacol Res, vol.45, pp.69-72, 2002.

E. Fantini, L. Demaison, E. Sentex, A. Grynberg, and P. Athias, Some Biochemical Aspects of the Protective Effect of Trimetazidine on Rat Cardiomyocytes During Hypoxia and Reoxygenation, Journal of Molecular and Cellular Cardiology, vol.26, issue.8, pp.949-58, 1994.
DOI : 10.1006/jmcc.1994.1116

R. Belardinelli, Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy, Rev Port Cardiol, vol.19, pp.35-44, 2000.

. Maridonneau-parini and C. Harpey, Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells., British Journal of Clinical Pharmacology, vol.8, issue.2, pp.148-151, 1986.
DOI : 10.1111/j.1365-2125.1985.tb05047.x

D. Feuvray, Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low-and zero-flow ischaemia, Cardiovasc Res, vol.47, pp.688-96, 2000.

E. Castedo, J. Segovia, C. Escudero, B. Olmedilla, F. Granado et al., Ischemia-Reperfusion Injury During Experimental Heart Transplantation. Evaluation of Trimetazidine's Cytoprotective Effect, Revista Espa??ola de Cardiolog??a (English Edition), vol.58, issue.8, pp.941-50, 2005.
DOI : 10.1016/S1885-5857(06)60377-0

Y. Ruixing, L. Wenwu, and R. Ghazali, Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion, Translational Research, vol.149, issue.3, pp.152-60, 2007.
DOI : 10.1016/j.trsl.2006.11.004

P. Kantor, L. A. Kozak, R. Lopaschuk, and G. , The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase, Circulation Research, vol.86, issue.5
DOI : 10.1161/01.RES.86.5.580

. Va, The protective effect of trimetazidine on the myocardium against reperfusion injury during thrombolytic therapy of acute infarction, Eksp Klin Farmakol, vol.67, pp.27-30, 2004.

J. Tillement, Evidence for the existence of [3H]-trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore, Br J Pharmacol, vol.123, pp.1385-94, 1998.

E. Orlova, M. Iiu, M. Matveeva, V. Lupanov, L. Samo?lenko et al., Assessment of antianginal and antiischemic effect of trimetazidine and its effects on myocardial perfusion in patients with ischemic heart disease and stable angina, Kardiologiia, vol.44, pp.23-31, 2004.

U. Thadani, Selection of optimal therapy for chronic stable angina, Current Treatment Options in Cardiovascular Medicine, vol.351, issue.suppl 1, pp.23-35, 2006.
DOI : 10.1007/s11936-006-0023-9

A. Onay-besikci and S. Ozkan, Trimetazidine Revisited: A Comprehensive Review of the Pharmacological Effects and Analytical Techniques for the Determination of Trimetazidine, Cardiovascular Therapeutics, vol.319, issue.2, pp.147-65, 2008.
DOI : 10.2174/138620707782152425

F. Kuralay, E. Altekin, A. Yazlar, B. Onvural, and O. Goldeli, Suppression of Angioplasty-Related Inflammation by Pre-Procedural Treatment with Trimetazidine, The Tohoku Journal of Experimental Medicine, vol.208, issue.3
DOI : 10.1620/tjem.208.203

M. Ikizler, S. Dernek, B. Sevin, and T. Kural, Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia, The Anatolian journal of cardiology, vol.3, pp.303-311, 2003.

J. Aussedat, A. Ray, L. Kay, M. Verdys, C. Harpey et al., Improvement of Long-Term Preservation of Isolated Arrested Rat Heart, Journal of Cardiovascular Pharmacology, vol.21, issue.1, pp.128-163, 1993.
DOI : 10.1097/00005344-199301000-00019

F. Boucher, D. Hearse, and L. Opie, Effects of Trimetazidine on Ischemic Contracture in Isolated Perfused Rat Hearts, Journal of Cardiovascular Pharmacology, vol.24, issue.1, pp.45-54, 1994.
DOI : 10.1097/00005344-199407000-00008

J. Camilleri, D. Joseph, J. Fabiani, D. Amat, C. Gueniot et al., Experimental Myocardial Infarction in the Rat as a Quantitative Model for the Study of Anti-Ischemic Interventions, Pathology - Research and Practice, vol.172, issue.1-2, pp.42-52, 1981.
DOI : 10.1016/S0344-0338(81)80121-5

A. Drake-holland, P. Belcher, J. Hynd, and M. Noble, Infarct size in rabbits: a modified method illustrated by the effects of propranolol and trimetazidine

J. Cahn, M. Borzeix, J. Angignard, S. Weber, and D. Angignard, Intérêt de la trimétazidine dans l'infarctus expérimental du myocarde en phase aigüe et sub-aigüe et dans la pathologie post-infarctus, pp.52-62, 1984.

F. Williams, K. Tanda, M. Kus, and T. Williams, Trimetazidine Inhibits Neutrophil Accumulation After Myocardial Ischaemia and Reperfusion in Rabbits, Journal of Cardiovascular Pharmacology, vol.22, issue.6, pp.828-833, 1993.
DOI : 10.1097/00005344-199312000-00008

Q. Timour, J. Aupetit, J. Loufoua-moundanga, I. Gerentes-chassagne, I. Kioueh et al., Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.343, issue.6, pp.645-651, 1991.
DOI : 10.1007/BF00184297

J. Renaud, Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis, Cardiovascular Drugs and Therapy, vol.50, issue.Suppl 26, pp.677-686, 1988.
DOI : 10.1007/BF02125756

J. Didier, J. Roux, D. Violot, and E. Justrabo, Les effets de la trimétazidine sur le coeur isolé perfusé de rat en hypoxie : étude hémodynamique et histologique, pp.28-34, 1984.

F. Takenaka, M. Sakanaski, A. Watanabe, S. Takeo, H. Araki et al., Effects of trimetazidine on the coronary circulation and myocardial metabolism in the dog, PharmacometricsOyo Yakuri, vol.11, pp.429-435, 1976.

J. Hugtenburg, T. Jap, M. Mathy, P. Van-heiningen, V. Bohnenn et al., Cardioprotective effect of trimetazidine and nifedipine in guinea-pig hearts subjected to ischaemia, Arch Int Pharmacodyn Ther, vol.300, pp.186-208, 1989.

L. Rochette, M. Fitoussi, and J. Bralet, Effet du prétraitement par la trimétazidine sur le métabolisme énergétique du coeur isolé de rat soumis à une ligature coronaire et perfusée en normoxie ou hypoxie, Gaz Med France, vol.91, pp.17-21, 1984.

N. Lavanchy, J. Martin, and A. Rossi, Trimetazidine preservation of the energy potential of the myocardium during ischemia and reperfusion. Phosphorus NMR spectroscopy study of the isolated heart], Presse Med, vol.15, pp.1758-61, 1986.

A. Rossi, N. Lavanchy, and J. Martin, Antiischemic effects of trimetazidine: 31P-NMR spectroscopy study in the isolated rat heart, Cardiovascular Drugs and Therapy, vol.1, issue.S4, pp.812-815, 1990.
DOI : 10.1007/BF00051281

G. Pierce and M. Czubryt, The contribution of ionic imbalance to ischemia/reperfusion-induced injury, J Mol Cell Cardiol, vol.27, pp.53-63, 1995.

A. Lombet, C. Abraham, N. Nagel, and J. Renaud, Trimétazidine et échanges ioniques transmembranaires, Arch Mal Coeur Vaiss, vol.3, p.34, 1989.

T. El-kady, K. El-sabban, M. Gabaly, A. Sabry, and S. Abdel-hady, Effects of Trimetazidine on Myocardial Perfusion and the Contractile Response of Chronically Dysfunctional Myocardium in Ischemic Cardiomyopathy, American Journal of Cardiovascular Drugs, vol.5, issue.2, pp.271-279, 2005.
DOI : 10.2165/00129784-200505040-00006

E. Uslenghi, Trimetazidine improves myocardial perfusion and left ventricular function in ischemic left ventricular dysfunction, Clin Nucl Med, vol.29, pp.117-125, 2004.

J. Jin, Effects of trimetazidine on myocardial metabolism evaluated by PET-CT in patients with ischemic cardiomyopathy], Zhonghua Xin Xue Guan Bing Za Zhi (Chinese journal of cardiovascular diseases), vol.36, pp.36-45, 2008.

R. Belardinelli, F. Lacalaprice, E. Faccenda, and L. Volpe, Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation, European Journal of Cardiovascular Prevention & Rehabilitation, vol.93, issue.5A, pp.533-573, 2008.
DOI : 10.1097/HJR.0b013e328304feec

V. Chaloupka, Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)], Vnitr Lek, vol.52, pp.609-623, 2006.

H. Sisakian, A. Torgomyan, and A. Barkhudaryan, The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy, Acta Cardiologica, vol.62, issue.5, pp.493-502, 2007.
DOI : 10.2143/AC.62.5.2023413

Z. Grabczewska, T. Bia?oszy?ski, P. Szyma?ski, A. Sukiennik, I. Swiatkiewicz et al., The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease, Cardiol J, vol.15, pp.344-50, 2008.

G. Jackson, Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents, Int J Clin Pract, vol.55, pp.256-61, 2001.

J. Detry, P. Sellier, and S. Pennaforte, Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina

H. Szwed, Clinical benefits of trimetazidine in patients with recurrent angina

L. Lee, J. Horowitz, and M. Frenneaux, Metabolic manipulation in ischaemic heart disease, a novel approach to treatment, European Heart Journal, vol.25, issue.8, pp.634-675, 2004.
DOI : 10.1016/j.ehj.2004.02.018

M. Emre, I. Karaaylali, M. San, A. Demirkazik, and S. Kavak, The acute effect of trimetazidine on the high frequency fatigue in the isolated Rat diaphragm muscle, Archives of Pharmacal Research, vol.64, issue.Suppl 4
DOI : 10.1007/BF02980165

V. Maupoil, R. L. Tabard, A. Clauser, P. Harpey, and C. , Direct Measurement of Free Radical Generation in Isolated Rat Heart by Electron Paramagnetic Resonance Spectroscopy : Effect of Trimetazidine, Adv Exp Med Biol, vol.264, pp.373-379, 1990.
DOI : 10.1007/978-1-4684-5730-8_58

S. Mouhieddine and J. De-leiris, Effect of a 5 day trimetazidine pretreatment in a model of ischemic and reperfused isolated rat heart : spin trapping experiments

P. Lemos, A. Hoye, and P. Serruys, Recurrent angina after revascularization: an emerging problem for the clinician, Coron Artery Dis, vol.15, pp.11-16, 2004.

D. Pauly and C. Pepine, Ischemic heart disease: Metabolic approaches to management, Clinical Cardiology, vol.43, issue.8, pp.439-480, 2004.
DOI : 10.1002/clc.4960270802

W. Stanley, Myocardial Energy Metabolism During Ischemia and the Mechanisms of Metabolic Therapies, Journal of Cardiovascular Pharmacology and Therapeutics, vol.9, issue.1 suppl, pp.31-45, 2004.
DOI : 10.1177/107424840400900104

N. Kudo, A. Barr, R. Barr, S. Desai, and G. Lopaschuk, High Rates of Fatty Acid Oxidation during Reperfusion of Ischemic Hearts Are Associated with a Decrease in Malonyl-CoA Levels Due to an Increase in 5'-AMP-activated Protein Kinase Inhibition of Acetyl-CoA Carboxylase, Journal of Biological Chemistry, vol.270, issue.29, pp.17513-17533, 1995.
DOI : 10.1074/jbc.270.29.17513

A. Wolff, H. Rotmensch, W. Stanley, and R. Ferrari, Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective, Heart Failure Reviews, vol.7, issue.2, pp.187-203, 2002.
DOI : 10.1023/A:1015384710373

M. Marzilli, Persistent Angina, American Journal Cardiovascular Drugs, vol.25, issue.1, pp.37-41, 2004.
DOI : 10.2165/1153643-S0-000000000-00000

Q. Timour, B. Bui-xuan, G. Faucon, and J. Aupetit, Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia, Cardiovascular Drugs and Therapy, vol.46, issue.Suppl 1, pp.447-54, 1996.
DOI : 10.1007/BF00051109

L. Gettes, W. Cascio, T. Johnson, and W. Fleet, Local Myocardial Biochemical and Ionic Alterations During Myocardial Ischaemia and Reperfusion, Drugs, vol.42, issue.Supplement 1
DOI : 10.2165/00003495-199100421-00004

M. Tani, Overload in Reperfused Ischemic Myocardium, Annual Review of Physiology, vol.52, issue.1
DOI : 10.1146/annurev.ph.52.030190.002551

J. Van-emous, M. Nederhoff, T. Ruigrok, and C. Van-achteld, The Role of the Na+Channel in the Accumulation of Intracellular Na+During Myocardial Ischemia: Consequences for Post-ischemic Recovery, Journal of Molecular and Cellular Cardiology, vol.29, issue.1, pp.85-96, 1997.
DOI : 10.1006/jmcc.1996.0254

+. Na and N. Atpase, + exchange are immediately active upon post-ischaemic reperfusion in isolated rat hearts, J Mol Cell Cardiol, vol.30, pp.337-348, 1998.